omega-n-methylarginine has been researched along with candesartan cilexetil in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (candesartan cilexetil) | Trials (candesartan cilexetil) | Recent Studies (post-2010) (candesartan cilexetil) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 628 | 151 | 133 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | candesartan cilexetil (IC50) |
|---|---|---|---|
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | 0.2 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 2.4547 | |
| DNA polymerase kappa | Homo sapiens (human) | 7.4 | |
| DNA polymerase iota | Homo sapiens (human) | 6.2 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.7244 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delles, C; Harazny, J; Michelson, G; Oehmer, S; Schmieder, RE; WÃĪrntges, S | 1 |
1 trial(s) available for omega-n-methylarginine and candesartan cilexetil
| Article | Year |
|---|---|
Effect of nos inhibition on retinal arterial and capillary circulation in early arterial hypertension.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Blood Circulation; Blood Flow Velocity; Blood Pressure; Capillaries; Cardiac Output; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Humans; Hypertension; Infusions, Intravenous; Nitric Oxide Synthase; omega-N-Methylarginine; Retinal Artery; Tetrazoles | 2006 |